These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9784452)

  • 1. Time trend analysis and variations in prescribing lipid lowering drugs in general practice.
    Baxter C; Jones R; Corr L
    BMJ; 1998 Oct; 317(7166):1134-5. PubMed ID: 9784452
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease: There Are Miles to Go Before We Sleep.
    Toth PP
    J Am Coll Cardiol; 2015 Oct; 66(17):1873-5. PubMed ID: 26493658
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of physician-managed lipid-lowering care in patients with coronary heart disease in two time periods (1994 and 1999).
    Smith DA; Harnick D; Kilaru R
    Am J Cardiol; 2001 Dec; 88(12):1417-9, A6. PubMed ID: 11741564
    [No Abstract]   [Full Text] [Related]  

  • 4. Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex, and temporary resident originated prescribing unit).
    Whynes DK; Baines DL; Tolley KH
    BMJ; 1996 Feb; 312(7029):488-9. PubMed ID: 8597684
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.
    Bittner V; Deng L; Rosenson RS; Taylor B; Glasser SP; Kent ST; Farkouh ME; Muntner P
    J Am Coll Cardiol; 2015 Oct; 66(17):1864-72. PubMed ID: 26493657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of statins in general practices, 1996-8: cross sectional study.
    Packham C; Pearson J; Robinson J; Gray D
    BMJ; 2000 Jun; 320(7249):1583-4. PubMed ID: 10845969
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in antibiotic prescribing.
    Wilcock M; Mackenzie I
    J Public Health Med; 2001 Dec; 23(4):357. PubMed ID: 11873903
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescribing incentive schemes in two NHS regions: cross sectional survey.
    Ashworth M; Golding S; Shephard L; Majeed A
    BMJ; 2002 May; 324(7347):1187-8. PubMed ID: 12016183
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent trends in the consumption of lipid-lowering drugs in Finland.
    Martikainen J; Klaukka T; Reunanen A; Peura S; Wahlroos H
    J Clin Epidemiol; 1996 Dec; 49(12):1453-57. PubMed ID: 8970497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003.
    Bartholomeeusen S; Vandenbroucke JP; Truyers C; Buntinx F
    BMC Fam Pract; 2008 Jun; 9():39. PubMed ID: 18590552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of therapeutic inertia in lipid lowering treatment of primary care patients with high cardiovascular risk].
    de Pablos Vicente MA; Leal Hernández M; Balanza Galindo S; Abellán Alemán J
    Aten Primaria; 2012 Mar; 44(3):e14-5. PubMed ID: 21724299
    [No Abstract]   [Full Text] [Related]  

  • 12. A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs.
    Avery AJ; Rodgers S; Heron T; Crombie R; Whynes D; Pringle M; Baines D; Petchey R
    BMJ; 2000 Jul; 321(7256):276-81. PubMed ID: 10915132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease.
    Harnick DJ; Cohen JL; Schechter CB; Fuster V; Smith DA
    Am J Cardiol; 1998 Jun; 81(12):1416-20. PubMed ID: 9645890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in prescribing patterns of general practitioners in Italy before and after the Reform Drug Act. A case study of changes in the city of Turin.
    Rolle C; Ferraro L; Marrazzo E; Ostino G
    Pharm World Sci; 1995 Sep; 17(5):158-62. PubMed ID: 8574211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis.
    Fleetcroft R; Cookson R; Steel N; Howe A
    Br J Gen Pract; 2011 Sep; 61(590):e556-64. PubMed ID: 22152735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of lipid-lowering agents in stroke and coronary heart disease: pharmacoeconomics.
    Rockson SG
    Curr Atheroscler Rep; 2000 Mar; 2(2):144-50. PubMed ID: 11122738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, sex, and temporary resident originated prescribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England.
    Roberts SJ; Harris CM
    BMJ; 1993 Aug; 307(6902):485-8. PubMed ID: 8305014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population.
    Larsen J; Andersen M; Kragstrup J; Gram LF
    Eur J Clin Pharmacol; 2001 Jul; 57(4):343-8. PubMed ID: 11549214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering therapy: do hospitals influence the prescribing behavior of general practitioners?
    Schröder-Bernhardi D; Dietlein G
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):317-21. PubMed ID: 12139209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic grand rounds: did Medicare Part D improve access to medications?
    Domino ME; Farley JF
    Psychiatr Serv; 2010 Feb; 61(2):118-20. PubMed ID: 20123814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.